OBJECTIVE: To investigate the mechanisms through which mechanical stress and lipopolysaccharide treatment modulate osteoblastic differentiation in periodontal ligament cells. MATERIALS AND METHODS: Cells were treated with lipopolysaccharide and/or mechanical strain applied with a Flexercell Strain Unit. Protein expression and mRNA were analyzed by Western blotting and reverse transcription-polymerase chain reaction, respectively. RESULTS: When lipopolysaccharide was co-applied with mechanical strain, the increase in the expression of bone morphogenetic protein-2, bone morphogenetic protein-7, and Runx2 mRNA seen with mechanical strain alone was restricted, but heme oxygenase-1 expression was further enhanced. Furthermore, pretreatment with an inhibitor of heme oxygenase-1 or inhibitors of p38, mitogen-activated protein kinase, JNK, phosphoinositide 3-kinases, protein kinase G, and nuclear factor kappaB restricted osteogenic differentiation induced by the application of lipopolysaccharide and mechanical strain. CONCLUSIONS: These results suggest that orthodontic force-induced osteogenesis in alveolar bone is inhibited by the accompanying periodontal inflammation via the upregulation of heme oxygenase-1 expression. Thus, the heme oxygenase-1 pathway could provide a possible therapeutic strategy to improve bone formation in orthodontic treatment.
OBJECTIVE: To investigate the mechanisms through which mechanical stress and lipopolysaccharide treatment modulate osteoblastic differentiation in periodontal ligament cells. MATERIALS AND METHODS: Cells were treated with lipopolysaccharide and/or mechanical strain applied with a Flexercell Strain Unit. Protein expression and mRNA were analyzed by Western blotting and reverse transcription-polymerase chain reaction, respectively. RESULTS: When lipopolysaccharide was co-applied with mechanical strain, the increase in the expression of bone morphogenetic protein-2, bone morphogenetic protein-7, and Runx2 mRNA seen with mechanical strain alone was restricted, but heme oxygenase-1 expression was further enhanced. Furthermore, pretreatment with an inhibitor of heme oxygenase-1 or inhibitors of p38, mitogen-activated protein kinase, JNK, phosphoinositide 3-kinases, protein kinase G, and nuclear factor kappaB restricted osteogenic differentiation induced by the application of lipopolysaccharide and mechanical strain. CONCLUSIONS: These results suggest that orthodontic force-induced osteogenesis in alveolar bone is inhibited by the accompanying periodontal inflammation via the upregulation of heme oxygenase-1 expression. Thus, the heme oxygenase-1 pathway could provide a possible therapeutic strategy to improve bone formation in orthodontic treatment.
Authors: M Kobayashi; T Takiguchi; R Suzuki; A Yamaguchi; K Deguchi; M Shionome; Y Miyazawa; T Nishihara; M Nagumo; K Hasegawa Journal: J Dent Res Date: 1999-10 Impact factor: 6.116
Authors: Yorihiro Akamatsu; Manabu Haga; Shivraj Tyagi; Kenichiro Yamashita; Aurelio Vicente Graça-Souza; Robert Ollinger; Eva Czismadia; G Aaron May; Emeka Ifedigbo; Leo E Otterbein; Fritz H Bach; Miguel P Soares Journal: FASEB J Date: 2004-02-20 Impact factor: 5.191
Authors: Dong Hyun Kim; Angela P Burgess; Ming Li; Peter L Tsenovoy; Francesco Addabbo; John A McClung; Nitin Puri; Nader G Abraham Journal: J Pharmacol Exp Ther Date: 2008-03-11 Impact factor: 4.030
Authors: Elizabeth Rendina-Ruedy; Jennifer L Graef; McKale R Davis; Kelsey D Hembree; Jeffrey M Gimble; Stephen L Clarke; Edralin A Lucas; Brenda J Smith Journal: J Bone Miner Metab Date: 2015-06-10 Impact factor: 2.626
Authors: Niels A J Cremers; Maarten Suttorp; Marlous M Gerritsen; Ronald J Wong; Coby van Run-van Breda; Gooitzen M van Dam; Katrien M Brouwer; Anne Marie Kuijpers-Jagtman; Carine E L Carels; Ditte M S Lundvig; Frank A D T G Wagener Journal: Front Med (Lausanne) Date: 2015-12-15
Authors: Christiaan M Suttorp; Rui Xie; Ditte M S Lundvig; Anne Marie Kuijpers-Jagtman; Jasper Tom Uijttenboogaart; René Van Rheden; Jaap C Maltha; Frank A D T G Wagener Journal: Front Physiol Date: 2016-07-19 Impact factor: 4.566